People: INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

35.92USD
30 Jun 2015
Change (% chg)

$1.26 (+3.64%)
Prev Close
$34.66
Open
$35.03
Day's High
$36.24
Day's Low
$35.03
Volume
364,873
Avg. Vol
266,235
52-wk High
$42.65
52-wk Low
$11.26

Search Stocks

Fourteau, Patrick 

Mr. Patrick P. Fourteau is Independent Director of Insys Therapeutics, Inc. Patrick P. Fourteau has served on board of directors since March 2011. Mr. Fourteau served as President and Chief Executive Officer of Shionogi from 2008 until 2010. Prior to the acquisition of Sciele Pharma by Shionogi, Mr. Fourteau served as President and CEO of Sciele Pharma from 2003 until 2008 and served on the board of directors of Sciele from 2004 until 2008. Mr. Fourteau served as President of Worldwide Sales of inVentiv Health, Inc. from 2000 to 2002. Mr. Fourteau served as President of various divisions of St. Jude Medical, Inc. from 1995 to 2000 and as an Executive of Eli Lilly and Company prior to 1995. Mr. Fourteau earned his MBA from Harvard University and a B.A. and M.A. in Mathematics from the University of California, Berkeley. We believe that Mr. Fourteau’s leadership experience in the pharmaceutical industry adds valuable expertise and insight to our board of directors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kapoor

--

Michael Babich

2,539,910

Darryl Baker

1,210,090

Franc Fosse

2,705,460

Patrick Fourteau

--

Pierre Lapalme

--
As Of  30 Dec 2014
Search Stocks